MedTrace Logo

Validity and Reliability of the Turkish Version of the Tele-Pulmonary Rehabilitation Acceptance Scale

NCT05871710 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-05-23

No results posted yet for this study

Summary

The objective of this research is to translate the Tele-Pulmonary Rehabilitation Acceptance Scale into Turkish and assess its reliability and accuracy.

Conditions

  • Pulmonary Disease
  • Telehealth
  • Pulmonary Rehabilitation

Interventions

OTHER

Turkish version of the Tele-Pulmonary Rehabilitation Acceptance Scale

The Tele-Pulmonary Rehabilitation Acceptance Scale is a measuring tool that assesses the level of acceptance towards telerehabilitation programs among healthcare providers and patients in the field of pulmonary rehabilitation. It is used to evaluate the attitudes, beliefs, and perceptions of potential users towards telerehabilitation, which is a form of healthcare delivery that utilizes telecommunication technology to provide remote rehabilitation services to patients. The scale is intended to provide a standardized data collection tool that can be used to measure the level of acceptance of telerehabilitation programs among different groups of potential users. This scale will be translated into Turkish by a researcher who has an advanced level of knowledge in English and whose native language is Turkish.

OTHER

Scale Evaluation Form

The healthcare providers and the patients will be asked about their opinions on the scale's construction, usefulness, and scope using a 100 mm visual analog scale.

Sponsors & Collaborators

  • Uskudar State Hospital

    lead OTHER_GOV

Principal Investigators

  • Mustafa H Temel, M.D. · Uskudar State Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2023-12-01
Completion
2024-03-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05871710 on ClinicalTrials.gov